negative effects of glp 1 drugs GLP-1 Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity Part 2 of a 3-Part

Effectiveness of semaglutide and tirzepatide in overweight and obese adults with type 1 diabetes

CONCLUSION The number of medications approved for the treatment of T2DM continues to expand

Encouragingly, GLP1R/GIPR agonists have demonstrated favorable outcomes in T2DM when studied in human clinical trials

doi:10.1056/NEJMoa2307563 27

Sinai Hospital, Toronto, Canada summarize and elucidate evidence that glucagon-like peptide-1 (GLP-1) receptor agonists (RAs), initially developed for the treatment of type 2 diabetes and weight management, demonstrate a surprisingly broad range of clinical benefits

In this issue of Ground Truths, Ill try and review this rapidly advancing field and where were headed